Donald I. Abrams, M.D. is an integrative oncologist at the UCSF Osher Center for Integrative Medicine and Professor Emeritus of Medicine at the University of California San Francisco. He was Chief of Hematology-Oncology at Zuckerberg San Francisco General from 2003-2017. He graduated from Brown University in 1972 and from the Stanford University School of Medicine in 1977. After completing an Internal Medicine residency at the Kaiser Foundation Hospital in San Francisco, he became a fellow in Hematology-Oncology at UCSF in 1980. During his fellowship, Dr.
Dr. Salomeh Keyhani is a Professor of Medicine at the University of California, San Francisco. She is the Director of the Center for Data to Discovery and Delivery Innovation, a VA-funded Center of Innovation focused on improving health and health care delivery. The Center brings together 27 UCSF investigators engaged in Health Systems Research (HSR) and supports research and training that advances patient centered health behavior change.
Nhung Nguyen, PhD, received her doctorate in Epidemiology from The University of Texas Health Science Center at Houston, TX, and her BS in Pharmacy from Hanoi University of Pharmacy, Vietnam. Her dissertation was among the first to examine smoking prevalence, nicotine dependence, and related factors among HIV-positive people in Vietnam. Her research interests include application of technology and data science in smoking cessation intervention among smokers with polysubstance use, and in smoking prevention among youth and young adults.
The focus of my research program in the Division of Clinical Pharmacology, as shown in the image below, is the utility and evaluation of biological markers (biomarkers) of tobacco use and exposure for epidemiology, risk assessment, product regulation, and identification of susceptibility factors.
Research has centered on hospital-based and out-patient clinical trials of smoking cessation. Completed studies include: Transdermal Nicotine Therapy for Hospitalized Smokers and Bupropion for Hospital-Based Smoking Cessation. Dr.
Dr. Schroeder is Distinguished Professor of Health and Health Care, Division of General Internal Medicine, Department of Medicine, UCSF, where he also heads the Smoking Cessation Leadership Center. The Center, funded by the Robert Wood Johnson Foundation and the Truth Initiative, works with leaders of more than 80 American health professional organizations and health care institutions to increase the cessation rate for smokers.
I study the health effects of air pollution in human subjects. I focus on the chemistry and toxicity of smoke and on how exposure to tobacco or cannabis smoke can cause heart and lung disease. My analysis of tobacco industry research showed that sidestream cigarette smoke (the primary constituent of secondhand cigarette smoke) is more toxic than the smoke that smokers inhale and that secondhand smoke becomes more toxic as it ages.
